High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines

Influenza viruses infect millions of people each year, resulting in significant morbidity and mortality in the human population. Therefore, generation of a universal influenza virus vaccine is an urgent need and would greatly benefit public health. Recombinant protein technology is an established va...

Descripción completa

Detalles Bibliográficos
Autores principales: Ecker, Jeffrey W., Kirchenbaum, Greg A., Pierce, Spencer R., Skarlupka, Amanda L., Abreu, Rodrigo B., Cooper, R. Ethan, Taylor-Mulneix, Dawn, Ross, Ted M., Sautto, Giuseppe A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565037/
https://www.ncbi.nlm.nih.gov/pubmed/32825605
http://dx.doi.org/10.3390/vaccines8030462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565037/
https://www.ncbi.nlm.nih.gov/pubmed/32825605
http://dx.doi.org/10.3390/vaccines8030462

Ejemplares similares